Yale University

HIV testing and sexual risk reduction counseling in office-based buprenorphine/naloxone treatment.

TitleHIV testing and sexual risk reduction counseling in office-based buprenorphine/naloxone treatment.
Publication TypeJournal Article
Year of Publication2013
AuthorsEdelman, Jennifer E., Brent A. Moore, Sarah Caffrey, Kathleen J. Sikkema, Emlyn S. Jones, Richard S. Schottenfeld, David A. Fiellin, and Lynn E. Fiellin
JournalJournal of addiction medicine
Volume7
Issue6
Pagination410-6
Date Published2013 Nov-Dec
ISSN1932-0620
KeywordsAdult, Buprenorphine, Feasibility Studies, Female, HIV Infections, Humans, Male, Naloxone, Narcotic Antagonists, Opiate Substitution Treatment, Opioid-Related Disorders, Patient Education as Topic, Risk Reduction Behavior, Sex Counseling, Sexual Behavior, Treatment Outcome
AbstractWe assessed the feasibility and preliminary efficacy of human immunodeficiency virus (HIV) testing with sexual risk reduction counseling for opioid-dependent patients initiating office-based buprenorphine/naloxone treatment.
DOI10.1097/ADM.0b013e3182a3b603
Alternate JournalJ Addict Med

External Links